Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

AIMS: It is recommended to perform atrial fibrillation ablation with continuous anticoagulation. Continuous apixaban has not been tested. METHODS AND RESULTS: We compared continuous apixaban (5 mg b.i.d.) to vitamin K antagonists (VKA, international normalized ratio 2–3) in atrial fibrillation patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchhof, Paulus, Haeusler, Karl Georg, Blank, Benjamin, De Bono, Joseph, Callans, David, Elvan, Arif, Fetsch, Thomas, Van Gelder, Isabelle C, Gentlesk, Philip, Grimaldi, Massimo, Hansen, Jim, Hindricks, Gerhard, Al-Khalidi, Hussein R, Massaro, Tyler, Mont, Lluis, Nielsen, Jens Cosedis, Nölker, Georg, Piccini, Jonathan P, De Potter, Tom, Scherr, Daniel, Schotten, Ulrich, Themistoclakis, Sakis, Todd, Derick, Vijgen, Johan, Di Biase, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110196/
https://www.ncbi.nlm.nih.gov/pubmed/29579168
http://dx.doi.org/10.1093/eurheartj/ehy176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110196/
https://www.ncbi.nlm.nih.gov/pubmed/29579168
http://dx.doi.org/10.1093/eurheartj/ehy176

Ejemplares similares